Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Michigan for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Michigan only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Michigan (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Andrew Sulich (NPI 1508946385)

Field	Value
Entity Type	Individual
Organization	Andrew Sulich
Address	29200 Harper Ave
City	Saint Clair Shores
State	MI
ZIP	48081
Taxonomy	Rheumatology Physician
NPI Enumerated	October 16, 2006

Payer Source	Total Paid
Medicare	$1.7M
Medicaid	$0

Key Findings

This provider is effectively a Medicare-only biller with Total Medicare revenue of $1.7M and no Medicaid billing on file (none below). That concentration makes payer exposure highly concentrated in Medicare reimbursement policy and beneficiary mix rather than split across payers.

Revenue is heavily concentrated in a small set of biologic drug codes: the precomputed top 3 codes account for 73.0% of this provider's total Medicare revenue, led by J3262 ($611K, 36.1%), J0129 ($404.3K, 23.9%), and J0717 ($219.2K, 13.0%). This indicates that a few high-cost injectable drugs dominate the practice’s revenue stream.

Code mix and revenue distribution point to an infusion-centered rheumatology practice model: high-revenue J‑codes for tocilizumab, abatacept, certolizumab and other biologics combined with chemotherapy/infusion administration codes (96413 $64.4K, 3.8%; 96401 $14.6K, 0.9%) suggest the provider administers parenteral biologic therapies under physician supervision rather than relying primarily on office-based E/M visits. The use of chemotherapy administration CPTs alongside J‑codes is consistent with billing patterns for in-office biologic infusions.

Competitive standing is uneven across the top drugs. J3262 ranks #28 of 618 providers nationally (96th percentile) and is described as notably above typical national volume, making the provider a major national-level contributor for tocilizumab; by contrast J0129 (rank #359 of 1221, 71th percentile) and J0717 (rank #365 of 848, 57th percentile) are in more typical national volume ranges.

Several administration and E/M items appear but contribute a small share of revenue relative to drug billing: 99214 accounts for $60.4K (3.6%) and 99213 for $16K (0.9%). This implies clinical follow-up visits exist but drug administration is the primary revenue driver, which affects staffing and facility needs (infusion chairs, nursing) more than high volumes of routine office visits.

The provider’s use of certain high-volume administration codes is also an outlier. 96413 ranks #402 of 7514 providers (95th percentile) and is labeled notably above typical national volume, reinforcing that infusion/administration services are a significant operational focus beyond just the J‑codes.

Tenure on file is long: NPI enumerated 2006-10-16 (~20 years ago), indicating an established billing history in Medicare that supports comparative ranking stability and suggests any supplier relationships or infusion workflows are likely long-standing.

From a payer risk and contract perspective, the combination of a single-payer footprint (Medicare only), high revenue concentration in three biologic J‑codes (73.0%), and exceptionally high national rank for J3262 means reimbursement changes, formulary edits, or site-of-care policies affecting these specific drugs could materially shift the provider’s revenue profile.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

22 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3262	Injection, tocilizumab, 1 mg	122,200	$10	$611K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	12,250	$30	$404.3K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	54,800	$1	$219.2K
J1602	Injection, golimumab, 1 mg, for intravenous use	16,850	$10	$168.5K
J0897	Injection, denosumab, 1 mg	5,340	$20	$96.1K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	610	$110	$64.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	630	$100	$60.4K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	280	$60	$15.9K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	250	$60	$14.6K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	120	$120	$14.3K

Showing 1–10 of 22

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Michigan Distribution

Andrew Sulich — 6 of 22 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Michigan

Full comparison — all codes billed, vs. state median

22 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	4	20	7,700	$30	$285.5K
J3262	1	10	26,240	$1	$191.1K
J0717	1	10	49,600	$1	$155.2K
J1602	9	20	14,430	$10	$153.5K
J0897	26	170	2,460	$20	$69.1K
96413	4	170	120	$100	$16.1K
99214	458	15,470	80	$80	$11.4K
99213	1,458	14,810	60	$60	$6.6K
99215	1,857	4,420	30	$110	$6K
96401	5	80	90	$50	$5.8K

Showing 1–10 of 22

Related Providers

Other providers that share a Tax Identification Number (TIN) with Andrew Sulich, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Amar Majjhoo	MI	Rheumatology Physician	$1.6M	$0

Nearby Providers

Other providers in the same ZIP code as Andrew Sulich, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Home Life Styles Inc	MI	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$10.9M
Alliance Physician Services Of Michigan, P.C.	MI	Urology Physician	$0	$8.9M
City Of St. Clair Shores	MI	Land Ambulance	$448.5K	$1M
Rima Tinawi-aljundi	MI	Anatomic Pathology Physician	$766.3K	$0
Eastside Associates, LLC	MI	Endoscopy Clinic/Center	$677.6K	$2.9K
Juan Frontera	MI	Urology Physician	$432.4K	$0
Shiva Maralani	MI	Urology Physician	$367.9K	$0
Michael Clune	MI	Ophthalmology Physician	$364.7K	$0
Scott Wilkinson	MI	Urology Physician	$349.2K	$0
Richard Cross	MI	Nephrology Physician	$296.6K	$0

Andrew Sulich — Billing Profile & Reimbursement Data

Sign up for Andrew Sulich — Billing Profile & Reimbursement Data policy alerts

Andrew Sulich — Billing Profile & Reimbursement Data

Sign up for Andrew Sulich — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References